Omalizimab

DRUG2 trials

Sponsors

Rabin Medical Center, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Conditions

Asthma PatientsChronic Idiopathic Urticaria

Phase 3

Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria

Rabin Medical CenterChronic Idiopathic Urticaria

Start: 2014-07-31End: 2016-06-30Target: 20Updated: 2014-06-18

Phase 4

ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression

CompletedNCT06869382

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationAsthma Patients

Start: 2023-01-01End: 2024-03-31Updated: 2025-03-11